Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis

被引：3
|
作者：
Tomelleri, Alessandro [1 ,2 ]
Rinaldi, Emma [1 ]
Campochiaro, Corrado [1 ,2 ]
Picchio, Maria [1 ,3 ]
Dagna, Lorenzo [1 ,2 ]
机构：
[1] Univ Vita Salute San Raffaele, Milan, Italy
[2] IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Dis, Milan, Italy
[3] IRCCS San Raffaele Hosp, Dept Nucl Med, Milan, Italy
来源：
RHEUMATOLOGY | 2022年
关键词：
D O I：
10.1093/rheumatology/keac416
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E24 / E26
页数：3
相关论文
共 50 条
  • [41] GLUCOCORTICOID-INDUCED COMPLICATIONS IN PATIENTS WITH POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS
    Buttgereit, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 42 - 42
  • [42] Glucocorticoid therapy in giant cell arteritis: comment on the article by Proven et al
    Docken, WP
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (05): : 868 - 868
  • [43] The role of tocilizumab as a rescue therapy in patients with glucocorticoid resistant giant cell arteritis
    Stretton, Brandon
    Tan, Yiran
    Hassall, Mark
    Simon, Sumu
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 917 - 917
  • [44] Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
    Amir Emamifar
    Torkell Ellingsen
    Anne Pernille Hermann
    Søren Hess
    Oke Gerke
    Ziba Ahangarani Farahani
    Per Syrak Hansen
    Inger Marie Jensen Hansen
    Peter Thye-Rønn
    Scientific Reports, 11
  • [45] Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
    Emamifar, Amir
    Ellingsen, Torkell
    Hermann, Anne Pernille
    Hess, Soren
    Gerke, Oke
    Farahani, Ziba Ahangarani
    Hansen, Per Syrak
    Hansen, Inger Marie Jensen
    Thye-Ronn, Peter
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] Stratified glucocorticoid monotherapy is safe and effective for most cases of giant cell arteritis
    Karabayas, Maira
    Dospinescu, Paula
    Locherty, Marc
    Moulindu, Paul
    Sobti, Manvi
    Hollick, Rosemary
    De Bari, Cosimo
    Robinson, Susan
    Olson, John
    Basu, Neil
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2020, 4 (02)
  • [47] Pernicious anemia in a patient with giant cell arteritis in long-term remission
    Hernández-Rodríguez, J
    Aguilera, E
    Grau, JM
    Cardellach, F
    Cid, MC
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (01) : 128 - 128
  • [48] Tocilizumab for giant cell arteritis: successful treatment with the occurrence of autoimmune thyreoiditis
    Jaspers, C.
    Reinbold, W.
    Turkiewicz, R.
    Lakomek, H.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 148 - 148
  • [49] Corticosteroid Therapy in Giant Cell Arteritis, Predictors for Long-Term Remission
    Boiardi, Luigi
    Restuccia, Giovanna
    Macchioni, Pierluigi
    Muratore, Francesco
    Cavazza, Alberto
    Cimino, Luca
    Aldigeri, Raffaella
    Catanoso, Mariagazia
    Pipitone, Nicolo
    Salvarani, Carlo
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [50] Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis: reply
    Pepper, Ruth
    Jayne, David
    Little, Mark
    Pusey, Charles
    Salama, Alan D.
    RHEUMATOLOGY, 2019, 58 (04) : 738 - 739
12345